News from us and our partners

Tags

Topics

0 results

News
6 March, 2024
Gradient Denervation Technologies enrolls first patient in early feasibility study of pulmonary artery denervation system
News
6 March, 2024
Asceneuron expands scientific Advisory Board with world leading experts in neurodegenerative diseases
News
3 March, 2024
Sitryx appoints COO and head of clinical operations
News
26 February, 2024
Mainstay Medical announces US$125 million equity financing transaction
News
21 February, 2024
HighLife appoints Prof. Stephen Brecker as CMO
News
20 February, 2024
Ex-Google DeepMind and Owkin scientists team up to create Bioptimus to build the first universal AI foundation model for biology
News
14 February, 2024
NodThera publishes preclinical data on NLRP3 inhibitors in obesity
News
13 February, 2024
deepc acquires Osimis platform: strengthening the AI infrastructure for radiology at scale
News
12 February, 2024
Mainstay Medical announces receipt of FDA approval for MRI labeling on ReActiv8® Restorative Neurostimulation System
News
9 February, 2024
Sensorion raises €50.5M with US and European investors
News
7 February, 2024
Artios Pharma appoints Christine Silverstein as CFO
News
7 February, 2024
Jazz Pharmaceuticals enters definitive agreement with Redx Pharma to acquire global rights to KRAS Inhibitor Program
News
6 February, 2024
Sofinnova publishes 2023 Impact Report
Feature
6 February, 2024
2023 Impact Report: A hands-on investment strategy driving positive change for the planet
News
31 January, 2024
AAVantgarde appoints Nina (Ekaterini) Kotsopoulou, PhD, as Chief Technical Officer
News
30 January, 2024
BrightHeart welcomes Michael Butchko as an independent board member

Gradient Denervation Technologies enrolls first patient in early feasibility study of pulmonary artery denervation system

Asceneuron expands scientific Advisory Board with world leading experts in neurodegenerative diseases

Sitryx appoints COO and head of clinical operations

Mainstay Medical announces US$125 million equity financing transaction

HighLife appoints Prof. Stephen Brecker as CMO

Ex-Google DeepMind and Owkin scientists team up to create Bioptimus to build the first universal AI foundation model for biology

NodThera publishes preclinical data on NLRP3 inhibitors in obesity

deepc acquires Osimis platform: strengthening the AI infrastructure for radiology at scale

Mainstay Medical announces receipt of FDA approval for MRI labeling on ReActiv8® Restorative Neurostimulation System

Sensorion raises €50.5M with US and European investors

Artios Pharma appoints Christine Silverstein as CFO

Jazz Pharmaceuticals enters definitive agreement with Redx Pharma to acquire global rights to KRAS Inhibitor Program

Sofinnova publishes 2023 Impact Report

2023 Impact Report: A hands-on investment strategy driving positive change for the planet

AAVantgarde appoints Nina (Ekaterini) Kotsopoulou, PhD, as Chief Technical Officer

BrightHeart welcomes Michael Butchko as an independent board member